Inherently antioxidant and antimicrobial tannic acid release from poly(tannic acid) nanoparticles with controllable degradability

Colloids Surf B Biointerfaces. 2016 Jun 1:142:334-343. doi: 10.1016/j.colsurfb.2016.03.006. Epub 2016 Mar 4.

Abstract

From a natural polyphenol, Tannic acid (TA), poly(TA) nanoparticles were readily prepared using a single step approach with three different biocompatible crosslinkers; trimethylolpropane triglycidyl ether (TMPGDE), poly(ethylene glycol) diglycidyl ether (PEGGE), and trisodium trimetaphosphate (STMP). P(TA) particles were obtained with controllable diameters between 400 to 800nm with -25mV surface charge. The effect of synthesis conditions, such as the emulsion medium, pH values of TA solution, and the type of crosslinker, on the shape, size, dispersity, yield, and degradability of poly(Tannic Acid) (p(TA)) nanoparticles was systematically investigated. The hydrolytic degradation amount in physiological pH conditions of 5.4, 7.4, and 9.0 at 37.5°C were found to be in the order TMPGDE<PEGGE<STMP. Furthermore, the degradation amounts of TA from p(TA) nanoparticles can be controlled by the appropriate choice of crosslinker, and the pH of releasing media. The highest TA release, 600mg/g, was obtained for TMPGDE-crosslinked p(TA) particles in intestinal pH conditions (pH 9) over 3 days; whereas, a slow and linear TA release profile over almost 30 days was obtained by using PEGGE-crosslinked p(TA) in body fluid pH conditions (pH 7.4). The total phenol content of p(TA) particles was calculated as 70±1μgmL(-1) for 170μgmL(-1) p(TA), and the trolox equivalent antioxidant capacity was found to be 2027±104mM trolox equivalent g(-1). Moreover, p(TA) nanoparticles demonstrated strong antimicrobial effects against common bacterial strains. More interestingly, with a higher concentration of p(TA) particles, higher blood clotting indices were obtained.

Keywords: Antioxidant and antimicrobial TA; Controlled degradation; p(TA) microgel/nanogel; p(Tannic acid) nanoparticle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / chemistry*
  • Anti-Infective Agents / pharmacology
  • Antioxidants / chemistry*
  • Antioxidants / pharmacology
  • Bacillus subtilis / drug effects
  • Bacillus subtilis / growth & development
  • Blood Coagulation / drug effects
  • Candida albicans / drug effects
  • Candida albicans / growth & development
  • Chromans / chemistry
  • Cross-Linking Reagents / chemistry*
  • Delayed-Action Preparations
  • Epoxy Compounds / chemistry
  • Escherichia coli / drug effects
  • Escherichia coli / growth & development
  • Gels
  • Hemolysis / drug effects
  • Humans
  • Hydrogen-Ion Concentration
  • Hydrolysis
  • Microbial Sensitivity Tests
  • Nanoparticles / chemistry*
  • Nanoparticles / ultrastructure
  • Particle Size
  • Phosphates / chemistry
  • Polymerization
  • Propylene Glycols / chemistry
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / growth & development
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / growth & development
  • Static Electricity
  • Tannins / chemistry*
  • Tannins / pharmacology

Substances

  • Anti-Infective Agents
  • Antioxidants
  • Chromans
  • Cross-Linking Reagents
  • Delayed-Action Preparations
  • Epoxy Compounds
  • Gels
  • Phosphates
  • Propylene Glycols
  • Tannins
  • 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid